PURPOSE: About half of the gynecological cancer (GC) survivors suffer from sexual dysfunctions and report a need for professional psychosexual support. The current study assessed (1) health care professionals' (HCP) current psychosexual support practices, (2) barriers to providing psychosexual support, and (3) HCP needs for training and assistance. METHODS: Semistructured interviews were conducted with gynecological oncologists (n = 10), radiation oncologists (n = 10), and oncology nurses involved in the treatment of GC (n = 10). RESULTS: The majority of the professionals reported discussing sexuality at least once with each patient. An important reason for addressing sexual functioning was to reassure patients that it is normal to experience sexual concerns and give them an opportunity to discuss sexual issues. About half of the professionals provided specific suggestions. Patients were rarely referred to a sexologist. Barriers encountered by professionals in the provision of psychosexual support were embarrassment and lack of time. HCP suggestions for the facilitation of psychosexual support provision were skills training, an increased availability of patient information, and the standard integration of psychosexual support in total gynecological cancer care. CONCLUSION: The majority of the professionals reported discussing sexuality at least once with every patient, but discussions of sexual functioning were often limited by time and attention. The development of comprehensive patient information about sexuality after GC is recommended as well as a more standard integration of psychosexual support in GC care and specific training.
PURPOSE: About half of the gynecological cancer (GC) survivors suffer from sexual dysfunctions and report a need for professional psychosexual support. The current study assessed (1) health care professionals' (HCP) current psychosexual support practices, (2) barriers to providing psychosexual support, and (3) HCP needs for training and assistance. METHODS: Semistructured interviews were conducted with gynecological oncologists (n = 10), radiation oncologists (n = 10), and oncology nurses involved in the treatment of GC (n = 10). RESULTS: The majority of the professionals reported discussing sexuality at least once with each patient. An important reason for addressing sexual functioning was to reassure patients that it is normal to experience sexual concerns and give them an opportunity to discuss sexual issues. About half of the professionals provided specific suggestions. Patients were rarely referred to a sexologist. Barriers encountered by professionals in the provision of psychosexual support were embarrassment and lack of time. HCP suggestions for the facilitation of psychosexual support provision were skills training, an increased availability of patient information, and the standard integration of psychosexual support in total gynecological cancer care. CONCLUSION: The majority of the professionals reported discussing sexuality at least once with every patient, but discussions of sexual functioning were often limited by time and attention. The development of comprehensive patient information about sexuality after GC is recommended as well as a more standard integration of psychosexual support in GC care and specific training.
Authors: Quirine D Pieterse; Gemma G Kenter; Cornelis P Maas; Cor D de Kroon; Carien L Creutzberg; J Baptist M Z Trimbos; Moniek M Ter Kuile Journal: Int J Gynecol Cancer Date: 2013-11 Impact factor: 3.437
Authors: Q D Pieterse; C P Maas; M M ter Kuile; M Lowik; M A van Eijkeren; J B M Z Trimbos; G G Kenter Journal: Int J Gynecol Cancer Date: 2006 May-Jun Impact factor: 3.437
Authors: Willemijn M Vermeer; Rinske M Bakker; Gemma G Kenter; Cor D de Kroon; Anne M Stiggelbout; Moniek M ter Kuile Journal: Psychooncology Date: 2014-09-02 Impact factor: 3.894
Authors: Emily K Hill; Stacey Sandbo; Emily Abramsohn; Jennifer Makelarski; Kristen Wroblewski; Emily R Wenrich; Stacy McCoy; Sarah M Temkin; S Diane Yamada; Stacy T Lindau Journal: Cancer Date: 2010-12-23 Impact factor: 6.860
Authors: Jennifer Barsky Reese; Kristen Sorice; Mary Catherine Beach; Laura S Porter; James A Tulsky; Mary B Daly; Stephen J Lepore Journal: J Cancer Surviv Date: 2016-11-17 Impact factor: 4.442
Authors: Isabelle Suvaal; Susanna B Hummel; Jan-Willem M Mens; Helena C van Doorn; Wilbert B van den Hout; Carien L Creutzberg; Moniek M Ter Kuile Journal: BMC Cancer Date: 2021-12-04 Impact factor: 4.430